<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01887210</url>
  </required_header>
  <id_info>
    <org_study_id>R01HD074846-01</org_study_id>
    <nct_id>NCT01887210</nct_id>
  </id_info>
  <brief_title>A Pilot Gaming Adherence Program for Youth Living With HIV</brief_title>
  <official_title>A Pilot Gaming Adherence Program for Youth Living With HIV</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rhode Island Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rhode Island Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will develop and test a novel, technology based intervention to improve treatment
      adherence among youth living with HIV who are taking antiretroviral medication. In the
      intervention youth will access an engaging and immersive app/game on their smartphone.Data
      about the opening of the smart pill bottle will be transferred from the bottle cap wirelessly
      and will trigger a text message about their adherence. While gaming, participants will gain
      information about their health, improve motivation for ARV and medical appointment adherence,
      and practice healthy behaviors. If the Intervention is found to be effective, it can be
      tested in a larger study and then disseminated to other youth on antiretroviral medications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Despite need for consistent adherence to medical care, youth living with HIV (YLWH) have
      suboptimal rates of retention in care and adherence to antiretroviral medication (ARV)
      treatment. There are few adherence studies with YLWH and the results are mixed, so there is a
      great need for the development of novel interventions. Results of adult HIV adherence studies
      indicate that participants are interested in using technology-based methods and are most
      receptive toward interventions that couple technological devices with motivational
      components. Pill taking monitoring devices have been found to be a sensitive measure of
      adherence to ARV medications, but do not lead to sustained improvements in adherence or
      intrinsic motivation when used alone. Building on this knowledge, this study will examine a
      multi-level technology that integrates a medication monitoring device WITH an interactive
      smartphone based app/game that is attractive and engaging to YLWH. This multi-level approach
      will integrate theory driven content with novel, but intuitive, technology to improve HIV
      treatment adherence.

      In this study, data on opening of the pill bottle will be transferred wirelessly from the
      bottle cap and a text on adherence sent to the phone. This developmental project will adapt
      and refine a smartphone app/game to include content consistent with the
      Information-Motivation-Behavioral Skills (IMB) Model. Creation and adaptation will occur from
      in-depth interviews with YLWH on ART (n=25) and an open trial of the Intervention (n=20).
      While gaming, participants will experience absorbing action-oriented adventures that increase
      information about their health (e.g. knowledge about HIV treatment), improve motivation (e.g.
      action-figures experience health benefits of adherence), and build skills (e.g. utilize
      clinicians as partners). A small randomized controlled pilot study (24 weeks) among 60 YLWH
      will examine the preliminary efficacy of the IMB Gaming Adherence Intervention (integration
      of the smart cap with the IMB informed app/game) compared to a comparison group who receive
      the smart cap and smartphone but no IMB game, on adherence and biological measures.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 2012</start_date>
  <completion_date type="Actual">August 2017</completion_date>
  <primary_completion_date type="Actual">January 9, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Log10 HIV-1 Viral Load</measure>
    <time_frame>24 weeks</time_frame>
    <description>Log viral load at end of study for participants with available viral load data (Log10 copies/ml)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Electronically Measured Past 7-day Adherence</measure>
    <time_frame>24 weeks</time_frame>
    <description>Past 7 day medication adherence as measured by electronic medication monitoring device.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Kept Medical Appointments</measure>
    <time_frame>24 weeks</time_frame>
    <description>Number of kept medical appointments since baseline.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Information-Motivation-Behavioral Skills (IMB) Antiretroviral Therapy (ART) Behavioral Skills Scale</measure>
    <time_frame>24 weeks</time_frame>
    <description>Behavioral Skills subscale from the Information-Motivation-Behavioral Skills (IMB) scale. This subscale measures self-efficacy for adherence to medical care related to antiretroviral medication and treatment. Five items were summed to get a total Behavioral Skills subscale score. Scores range from 5-25 where higher scores indicate greater self-efficacy for adherence to medical care related to ART medication and treatment.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">66</enrollment>
  <condition>Adherence to HIV Treatment and Medication</condition>
  <arm_group>
    <arm_group_label>IMB Gaming Adherence Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Combination of smart pill bottle cap with mobile gaming application tailored for those living with HIV</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Enhanced treatment as usual</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Smart pill bottle cap and mobile phone but no game</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>IMB Gaming Adherence Intervention</intervention_name>
    <description>Combination of smart pill bottle cap with mobile gaming application tailored for those living with HIV</description>
    <arm_group_label>IMB Gaming Adherence Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Enhanced treatment as usual</intervention_name>
    <description>Smart pill bottle cap and mobile phone but no game</description>
    <arm_group_label>Enhanced treatment as usual</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  English speaking

          -  in medical care for HIV and receiving antiretroviral treatment

          -  aware of their HIV status as per clinician and clinical record

          -  able to give consent/assent and not impaired by cognitive or medical limitations as
             per clinical assessment

          -  detectable viral load

        Exclusion Criteria:

          -  none
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>26 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Larry K Brown, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rhode Island Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Laura Whiteley, MD</last_name>
    <role>Study Director</role>
    <affiliation>Rhode Island Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rhode Island Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02903</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>June 24, 2013</study_first_submitted>
  <study_first_submitted_qc>June 25, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 26, 2013</study_first_posted>
  <results_first_submitted>March 16, 2018</results_first_submitted>
  <results_first_submitted_qc>August 28, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">September 26, 2018</results_first_posted>
  <last_update_submitted>August 28, 2018</last_update_submitted>
  <last_update_submitted_qc>August 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rhode Island Hospital</investigator_affiliation>
    <investigator_full_name>Dr. Larry K. Brown</investigator_full_name>
    <investigator_title>Professor of Psychiatry and Human Behavior</investigator_title>
  </responsible_party>
  <keyword>HIV</keyword>
  <keyword>youth</keyword>
  <keyword>medical adherence</keyword>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>IMB Gaming Adherence Intervention</title>
          <description>Combination of smart pill bottle cap with mobile gaming application tailored for those living with HIV</description>
        </group>
        <group group_id="P2">
          <title>Enhanced Treatment as Usual</title>
          <description>Smart pill bottle cap and mobile phone but no game</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
                <participants group_id="P2" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="29"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>The baseline analysis population includes 61 participants. Participants that completed baseline and at least one follow-up assessment were included in the analytic sample.</population>
      <group_list>
        <group group_id="B1">
          <title>IMB Gaming Adherence Intervention</title>
          <description>Combination of smart pill bottle cap with mobile gaming application tailored for those living with HIV</description>
        </group>
        <group group_id="B2">
          <title>Enhanced Treatment as Usual</title>
          <description>Smart pill bottle cap and mobile phone but no game</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="32"/>
            <count group_id="B2" value="29"/>
            <count group_id="B3" value="61"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22.5" spread="2.5"/>
                    <measurement group_id="B2" value="22.3" spread="2.5"/>
                    <measurement group_id="B3" value="22.4" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="61"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="59"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Started ARV in past 3 months</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gaming Status</title>
          <description>Participants were asked about how often they played video games.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Daily or almost daily</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not everyday</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or not reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sexual Orientation</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Heterosexual</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Homosexual</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="35"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Bisexual</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Undecided</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Log10 HIV-1 Viral Load</title>
        <description>Log viral load at end of study for participants with available viral load data (Log10 copies/ml)</description>
        <time_frame>24 weeks</time_frame>
        <population>Unable to extract viral load data from chart for 9 participants in IMB intervention and 1 in TAU+.</population>
        <group_list>
          <group group_id="O1">
            <title>IMB Gaming Adherence Intervention</title>
            <description>Combination of smart pill bottle cap with mobile gaming application tailored for those living with HIV</description>
          </group>
          <group group_id="O2">
            <title>Enhanced Treatment as Usual</title>
            <description>Smart pill bottle cap and mobile phone but no game</description>
          </group>
        </group_list>
        <measure>
          <title>Log10 HIV-1 Viral Load</title>
          <description>Log viral load at end of study for participants with available viral load data (Log10 copies/ml)</description>
          <population>Unable to extract viral load data from chart for 9 participants in IMB intervention and 1 in TAU+.</population>
          <units>Log10 copies/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.48" spread="2.07"/>
                    <measurement group_id="O2" value="1.82" spread="2.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Electronically Measured Past 7-day Adherence</title>
        <description>Past 7 day medication adherence as measured by electronic medication monitoring device.</description>
        <time_frame>24 weeks</time_frame>
        <population>Missing data for n=1 from TAU+</population>
        <group_list>
          <group group_id="O1">
            <title>IMB Gaming Adherence Intervention</title>
            <description>Combination of smart pill bottle cap with mobile gaming application tailored for those living with HIV</description>
          </group>
          <group group_id="O2">
            <title>Enhanced Treatment as Usual</title>
            <description>Smart pill bottle cap and mobile phone but no game</description>
          </group>
        </group_list>
        <measure>
          <title>Electronically Measured Past 7-day Adherence</title>
          <description>Past 7 day medication adherence as measured by electronic medication monitoring device.</description>
          <population>Missing data for n=1 from TAU+</population>
          <units>proportion of adherence</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.29" spread="0.36"/>
                    <measurement group_id="O2" value="0.32" spread="0.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Kept Medical Appointments</title>
        <description>Number of kept medical appointments since baseline.</description>
        <time_frame>24 weeks</time_frame>
        <population>Unable to pull information from chart for 9 participants in the IMB intervention and 6 in the TAU+ groups.</population>
        <group_list>
          <group group_id="O1">
            <title>IMB Gaming Adherence Intervention</title>
            <description>Combination of smart pill bottle cap with mobile gaming application tailored for those living with HIV</description>
          </group>
          <group group_id="O2">
            <title>Enhanced Treatment as Usual</title>
            <description>Smart pill bottle cap and mobile phone but no game</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Kept Medical Appointments</title>
          <description>Number of kept medical appointments since baseline.</description>
          <population>Unable to pull information from chart for 9 participants in the IMB intervention and 6 in the TAU+ groups.</population>
          <units>appointments kept since baseline</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.78" spread="1.24"/>
                    <measurement group_id="O2" value="1.74" spread="1.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Information-Motivation-Behavioral Skills (IMB) Antiretroviral Therapy (ART) Behavioral Skills Scale</title>
        <description>Behavioral Skills subscale from the Information-Motivation-Behavioral Skills (IMB) scale. This subscale measures self-efficacy for adherence to medical care related to antiretroviral medication and treatment. Five items were summed to get a total Behavioral Skills subscale score. Scores range from 5-25 where higher scores indicate greater self-efficacy for adherence to medical care related to ART medication and treatment.</description>
        <time_frame>24 weeks</time_frame>
        <population>Missing data for n=2 from IMB intervention, n=2 from TAU+</population>
        <group_list>
          <group group_id="O1">
            <title>IMB Gaming Adherence Intervention</title>
            <description>Combination of smart pill bottle cap with mobile gaming application tailored for those living with HIV</description>
          </group>
          <group group_id="O2">
            <title>Enhanced Treatment as Usual</title>
            <description>Smart pill bottle cap and mobile phone but no game</description>
          </group>
        </group_list>
        <measure>
          <title>Information-Motivation-Behavioral Skills (IMB) Antiretroviral Therapy (ART) Behavioral Skills Scale</title>
          <description>Behavioral Skills subscale from the Information-Motivation-Behavioral Skills (IMB) scale. This subscale measures self-efficacy for adherence to medical care related to antiretroviral medication and treatment. Five items were summed to get a total Behavioral Skills subscale score. Scores range from 5-25 where higher scores indicate greater self-efficacy for adherence to medical care related to ART medication and treatment.</description>
          <population>Missing data for n=2 from IMB intervention, n=2 from TAU+</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.83" spread="4.68"/>
                    <measurement group_id="O2" value="19.48" spread="5.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up to 24 weeks</time_frame>
      <desc>Adverse events as described in the study protocol were reported by study staff to the principle investigator.</desc>
      <group_list>
        <group group_id="E1">
          <title>IMB Gaming Adherence Intervention</title>
          <description>Combination of smart pill bottle cap with mobile gaming application tailored for those living with HIV</description>
        </group>
        <group group_id="E2">
          <title>Enhanced Treatment as Usual</title>
          <description>Smart pill bottle cap and mobile phone but no game</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>This study had a small sample. Participants were recruited from Jackson, MS, so this sample is not nationally representative. There is no perfect measure of adherence. Self-report and electronic monitoring devices assessments differed.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Larry Brown</name_or_title>
      <organization>Rhode Island Hospital</organization>
      <phone>401-793-8808</phone>
      <email>lkbrown@lifespan.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

